LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device
Advanced Medical Solutions Limited · Decision date Jan 14, 2026
What did the FDA approve?
FDA records P220024/S005 as a supplement to PMA P220024, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jan 14, 2026.
FDA approval order statement
approval of the revised protocol to enhance enrollment of the LIQUFIX Post-Approval Study (PAS). The changes are, namely, revising the enrollment milestone dates. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P220024.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Jan 14, 2026
- FDA change category
- Postapproval Study Protocol
Regulatory record facts
- Identifier
- P220024/S005
- Regulatory pathway
- PMA supplement
- Applicant
- Advanced Medical Solutions Limited
- Product code
- PLJ
- Decision code
- APPR
- Decision date
- Jan 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tissue adhesive internal use.
- Applicant
- Advanced Medical Solutions Limited
- Product code
- PLJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220024. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220024 · Original PMA
LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device
P220024/S005 received
Application receipt date recorded by FDA.
P220024/S005 · FDA decision
Normal 180 Day Track No User Fee
P220024/S007 · Related supplement
LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation Device
Timeline entries are records held by MedtechLedger for P220024. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220024
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Advanced Medical Solutions Limited | PMA approval | Jun 2, 2023 | FDA | |
| Advanced Medical Solutions Limited | PMA supplement | Oct 23, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Advanced Medical Solutions Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Western Wood Way, Langage Science Park, Plymouth, PL7 5BG
Sources and methodology
- Original FDA record: P220024/S005
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
